Literature DB >> 2539469

Effects of phencyclidine-like drugs on punished behavior in rats.

J H Porter1, J L Wiley, R L Balster.   

Abstract

The effects of phencyclidine (PCP) and a number of PCP-like drugs on punished responding in rats were compared to those of chlordiazepoxide and morphine. Twenty rats, trained to lever-press for food reinforcement, were tested under a modified Geller-Seifter procedure using a multiple schedule with responding in one component reinforced under a fixed-interval 60-sec schedule while each response in the other component resulted in both food and brief electric shock presentation. Chlordiazepoxide, PCP, etoxadrol, (+)-N-allylnormetazocine and (-)-beta-cyclazocine all resulted in selective increases in rates of responding during the punishment component. Two drugs with predominant opiate-agonist actions in vivo, (-)-alpha-cyclazocine and morphine, did not increase punished responding at any dose tested. These results confirm previous research using pigeons that had shown antipunishment effects of PCP and provide further evidence for an overlap in the pharmacology of PCP-like drugs and depressant drugs such as barbiturates and benzodiazepines. The concordance between the discriminative stimulus properties and antipunishment effects of PCP-like drugs and actions at the PCP receptor suggests that the PCP receptor may play a role in both behavioral actions of this group of drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539469

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey.

Authors:  F S Guimarães; A P Carobrez; J C De Aguiar; F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Lorazepam reinstates punishment-suppressed remifentanil self-administration in rats.

Authors:  Leigh V Panlilio; Eric B Thorndike; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2004-10-27       Impact factor: 4.530

3.  MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior.

Authors:  D C Blanchard; R J Blanchard; A de P Carobrez; R Veniegas; R J Rodgers; J K Shepherd
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 4.  Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion.

Authors:  Christopher Barkus; Stephen B McHugh; Rolf Sprengel; Peter H Seeburg; J Nicholas P Rawlins; David M Bannerman
Journal:  Eur J Pharmacol       Date:  2009-10-15       Impact factor: 4.432

5.  Drug discrimination based on the competitive N-methyl-D-aspartate antagonist, NPC 12626.

Authors:  J Willetts; D J Bobelis; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Interaction of sigma and PCP-like drugs on operant behaviors in the rat.

Authors:  T J Hudzik; B L Slifer
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Anxiolytic effect of glycine antagonists microinjected into the dorsal periaqueductal grey.

Authors:  M G Matheus; R L Nogueira; A P Carobrez; F G Graeff; F S Guimarães
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

8.  Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions.

Authors:  Waseem Hassan; Carlos Eduardo Barroso Silva; Imdad Ullah Mohammadzai; Joao Batista Teixeira da Rocha; Landeira-Fernandez J
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.